Replimune’s RP1+nivolumab melanoma BLA faces an FDA decision by Apr 10, 2026. The current cash runway extends to Q1'27. See ...
The 2026 NYC Access Control Compliance Guide is designed to reduce uncertainty for institutions and risk-averse buyers. It ...
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN ...
TheNewswire - Rockport, Ontario – New Age Metals Inc. (TSX.V: NAM | OTCQB: NMTLF | FSE: P7J) (“NAM” or the “Company”) is ...
Nord Precious Metals (TSXV: NTH) is reporting this morning that they have completed three holes to date under an ongoing ...
With reported 3x speed gains and limited degradation in output quality, the method targets one of the biggest pain points in production AI systems: latency at scale.
Imagine trying to design a key for a lock that is constantly changing its shape. That is the exact challenge we face in ...
In a Phase III randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better ...
Discover how AI is transforming nutritional science by turning complex diet and omics data into predictive tools that reshape chronic disease prevention and personalized care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results